Dr. Patricia Campbell is an IP Partner at Jones Day. As a former associate professor of medicinal chemistry at the University of Washington, Seattle, along with her more than 15 years of patent experience, Patricia provides impactful counseling to clients in all aspects of patent portfolio development in the pharmaceutical and biotechnology sectors, including small molecule pharmaceuticals, antibodies and antibody-drug conjugates, antisense oligonucleotides, diagnostics, enzyme replacements, and machine learning / in silico screening methods for drug identification and development. In addition to patent procurement and portfolio management, Patricia advises clients regarding patentability, patent term extensions, Orange Book listing, validity, infringement, and freedom-to-operate issues; and performs due diligence evaluations of patent portfolios for possible investment, licensing, or acquisition. Patricia has a Ph.D. in Biochemistry, and B.Sc. in Biochemistry and Chemistry.